Modular Construction Market for Biotechnology and Pharmaceutical Industry (3rd Edition), 2023-2035: Distribution by Size of Facility (Small, Mid-sized, Large and Very Large), Type of Industry Served (Pharmaceutical and Biotechnology), Type of Modular Construct (Hybrid Skid Modular Constructs, Skid-Mounted Modular Constructs, Plug-and-Play Modular Constructs, Truckable Modular Constructs and Other Modular Constructs), Type of Construction Component (Process Equipment, Base Building, Mechanical, Electrical and Plumbing System, Process Commodities and Other Construction Components), Purpose of Facility (Manufacturing Facilities, Aseptic Filling Facilities, Research and Development Facilities and Other Facilities), Scale of Operation (Clinical and Commercial), Type of Product (Cell and Gene Therapies, Vaccines, Biosimilars, Monoclonal Antibodies, Advanced Pharmaceuticals, Sterile Products, Viral Vectors and Other Products), Type of Expansion (New Facilities, Facility Expansions and Planned Expansions), Type of Modular Construction (Relocatable Modular Construction, Permanent Modular Construction), Type of Material Used (Steel, Wood and Concrete) and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, 2023-2035
The global modular construction is expected to reach USD 2.5 billion in 2023 anticipated to grow at a CAGR of 9.9% during the forecast period 2023-2035.
The pharmaceutical industry is seeing a notable surge in the embrace of modular facilities, with predictions showing a Compound Annual Growth Rate (CAGR) of 10% for the modular construction market in the upcoming period. These prefabricated buildings are emerging as a promising alternative to traditional pharma and biotech manufacturing facilities. Modular construction involves assembling structures using pre-made modular units in a controlled factory off-site, later bringing these units together at the intended location. Importantly, this off-site approach significantly reduces concerns related to weather, accounting for 60% to 90% of typical project issues. Moreover, modular facilities can be built 40% faster than conventional methods, which often span up to three years. As a result, many pharmaceutical companies are shifting focus from traditional plants to modular facilities due to the manifold advantages they offer. Providers of modular facilities are tailoring their offerings to meet the needs of various stakeholders involved in therapeutic development, covering areas such as cell and gene therapy, biosimilars, and vaccines. Modular manufacturing breaks down individual production processes like fermentation, purification, and formulation into distinct modules that can be easily put together and taken apart, enabling flexibility and scalability. This method also allows for the use of smaller-scale production units, offering greater adaptability to dynamic market demands. Furthermore, temporary modular buildings can be relocated based on the end-user's requirements after installation.
However, challenges such as managing large-scale production, complex decision-making, obtaining construction approvals, and securing initial financing may hinder the widespread adoption of modular construction. Overcoming these obstacles could position healthcare stakeholders to effectively harness modular constructs, potentially resulting in significant benefits like increased flexibility and faster time-to-market for new products.
Report Coverage
The pharmaceutical industry is seeing a notable surge in the embrace of modular facilities, with predictions showing a Compound Annual Growth Rate (CAGR) of 10% for the modular construction market in the upcoming period. These prefabricated buildings are emerging as a promising alternative to traditional pharma and biotech manufacturing facilities. Modular construction involves assembling structures using pre-made modular units in a controlled factory off-site, later bringing these units together at the intended location. Importantly, this off-site approach significantly reduces concerns related to weather, accounting for 60% to 90% of typical project issues. Moreover, modular facilities can be built 40% faster than conventional methods, which often span up to three years. As a result, many pharmaceutical companies are shifting focus from traditional plants to modular facilities due to the manifold advantages they offer. Providers of modular facilities are tailoring their offerings to meet the needs of various stakeholders involved in therapeutic development, covering areas such as cell and gene therapy, biosimilars, and vaccines. Modular manufacturing breaks down individual production processes like fermentation, purification, and formulation into distinct modules that can be easily put together and taken apart, enabling flexibility and scalability. This method also allows for the use of smaller-scale production units, offering greater adaptability to dynamic market demands. Furthermore, temporary modular buildings can be relocated based on the end-user's requirements after installation.
However, challenges such as managing large-scale production, complex decision-making, obtaining construction approvals, and securing initial financing may hinder the widespread adoption of modular construction. Overcoming these obstacles could position healthcare stakeholders to effectively harness modular constructs, potentially resulting in significant benefits like increased flexibility and faster time-to-market for new products.
Report Coverage
- The report conducts an analysis of the modular construction market, examining factors such as size of facility, type of industry served, type of modular construct, type of construction component, purpose of facility, scale of operation, type of product, type of facility, type of modular construction, type of material used and key geographical regions.
- It assesses market growth drivers, restraints, opportunities, and challenges, while evaluating potential advantages and obstacles faced by stakeholders. Furthermore, it provides insights into the competitive landscape for top market players.
- Revenue forecasts for market segments across five major regions are presented. Key research findings offer an overarching view of the present status and anticipated evolution of the modular manufacturing market in short, mid, and long-term forecast periods.
- The introduction section covers fundamental concepts related to modular facilities, exploring various constructs, their primary applications in pharmaceutical and biotechnology sectors, and recent industry advancements.
- An in-depth analysis details the current market scenario, considering contributions from different service providers categorized by establishment year, company size, headquarters location, industries served, geographical coverage, compliance with Good Manufacturing Practices (GMP), types of modular construction, materials used, and quality certifications.
- A comprehensive review focuses on companies involved in modular cleanroom manufacturing, encompassing establishment year, company size, headquarters location, industries served, types of modular cleanrooms offered, cleanroom components provided, and quality certifications obtained.
- Examining the competitive landscape among modular facility service providers by company sizes involves ranking based on parameters like service strength, overall competitiveness, and partnership activities within their respective peer groups.
- Detailed profiles highlight key players offering modular facilities, featuring company overviews, service portfolio details, recent developments, key executive members, and informed outlooks on the companies' futures.
- The examination of industry partnerships between 2012-2022 includes analyzing partnership year, type, products, modular facility types, geographical locations, and active players involved.
- Detailed case studies on modular projects executed by manufacturers within the pharmaceutical and biotechnology sectors provide information on type, size, number, and location of these facilities.
- An insightful evaluation of facility construction trends in the pharmaceutical industry over seven years includes details about the top 20 pharma/biotech players, such as the number, type, purpose, investments, size, and locations of their established facilities.
- Lastly, a comprehensive framework facilitates the evaluation of cost and time-related advantages across diverse modular approaches, considering parameters like long-term benefits and sustainability, aiding end-users in informed decision-making.
- Cytiva
- G-Con Manufacturing
- Germfree
- IPM Technologies
- KeyPlants
- ModuleCo Pharma
- NNE
- Pharmadule
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
5. MARKET LANDSCAPE: MODULAR CLEANROOM MANUFACTURERS
5.1. Chapter Overview
5.2. Modular Cleanroom Manufacturers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained
6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-Con Manufacturing
7.3.1. Company Overview
7.3.2. Modular Facility-related Services
7.3.3. Modular Projects
7.3.4. Recent Developments and Future Outlook
7.4. Germfree
7.4.1. Company Overview
7.4.2. Modular Facility-related Services
7.4.3. Modular Projects
7.4.4. Recent Developments and Future Outlook
7.5. IPM Technologies
7.5.1. Company Overview
7.5.2. Modular Facility-related Services
7.5.3. Modular Projects
7.5.4. Recent Developments and Future Outlook
7.6. KeyPlants
7.6.1. Company Overview
7.6.2. Modular Facility-related Services
7.6.3. Modular Projects
7.6.4. Recent Developments and Future Outlook
7.7. ModuleCo Pharma
7.7.1. Company Overview
7.7.2. Modular Facility-related Services
7.7.3. Modular Projects
7.7.4. Recent Developments and Future Outlook
7.8. NNE
7.8.1. Company Overview
7.8.2. Modular Facility-related Services
7.8.3. Modular Projects
7.8.4. Recent Developments and Future Outlook
7.9. Pharmadule
7.9.1. Company Overview
7.9.2. Modular Facility-related Services
7.9.3. Modular Projects
7.9.4. Recent Developments and Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country
9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Versus Conventional Construction Methods
9.3. Return on Investment
9.4. Case Study: Facility Based on KUBio Platform
9.4.1. Cytiva KUBio Platform: Overview
9.4.2. Eden Biologics Kubio Modular Project in China: Overview and Construction Details
9.5. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.5.1. Analysis by Type of Modular Facility
9.5.2. Analysis by Size of Modular Facility
9.5.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.5.4. Leading Clients: Analysis by Number of Projects Received
9.5.5. Analysis by Location of Modular Facility
9.5.6. Analysis by Type of Facility and Size of Modular Facility
9.5.7. Analysis by Client and Location of Facility
10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Parameters
11.3. Key Assumptions and Methodology
11.4. Comparison of Intrinsic Factors
11.4.1. Analysis by Type of Material Used
11.4.2. Analysis by Type of Modular Construction
11.4.1. Analysis by Purpose of Facility
11.4.2. Analysis by Geographical Location
11.5. Integrated Outcome Modeling – Scenario Analysis
11.6. Integrated Outcome Modeling – Output Analysis
11.7. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Construction Market in the Pharmaceutical / Biotechnology Sector, 2023-2035
12.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-203
12.4.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035
12.4.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035
12.4.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035
12.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Construction Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Construction Market in the Biotechnology Industry, 2023-2035
12.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035
12.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035
12.7.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Buildings, 2023-2035
12.7.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035
12.7.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035
12.8 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing, 2023-2035
12.8.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling, 2023-2035
12.8.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development, 2023-2035
12.8.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Purposes, 2023-2035
12.9. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Scale, 2023-2035
12.9.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Scale, 2023-2035
12.10. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035
12.10.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035
12.10.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035
12.10.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035
12.10.8. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035
12.11. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035
12.11.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035
12.11.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035
12.12. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035
12.13. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035
12.13.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035
12.13.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035
12.14. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Geography, 2023 and 2035
12.14.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035
12.14.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035
12.14.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035
12.14.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035
12.14.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035
12.15. Concluding Remarks
13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.1. Company Snapshot
16.2.2. Interview Transcript
16.3. Environmental Systems Corporation
16.3.1. Company Snapshot
16.3.2. Interview Transcript
16.4. Exyte
16.4.1. Company Snapshot
16.4.2. Interview Transcript
16.5. G-Con Manufacturing
16.5.1. Company Snapshot
16.5.2. Interview Transcript
16.6. Modular Devices
16.6.1. Company Snapshot
16.6.2. Interview Transcript
16.7. ModWave
16.7.1. Company Snapshot
16.7.2. Interview Transcript
16.8. Subzero Engineering
16.8.1. Company Snapshot
16.8.2. Interview Transcript
16.9. Vernick
16.9.1. Company Snapshot
16.9.2. Interview Transcript
16.10. Zeton
16.10.1. Company Snapshot
16.10.2. Interview Transcript
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Historical Background
3.3. The Concept of Modular Facilities
3.3.1. Types of Modular Constructs
3.3.2. Modular Construction Process
3.4. Modular Construction in the Pharmaceutical Industry
3.4.1. Advantages of Modular Construction in the Pharmaceutical Industry
3.4.2. Modular Pharmaceutical Cleanrooms
3.4.2.1. Cleanroom Classifications and Current Standards
3.4.2.2. Regulations and Standards Concerning Modular Cleanroom Construction
3.5. Advantages of Modular Cleanrooms
3.6. Challenges and Future Prospects
4. MARKET LANDSCAPE: MODULAR FACILITY MANUFACTURERS
4.1. Chapter Overview
4.2. Modular Facility Manufacturers: Overall Market Landscape
4.2.1 Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Year of Establishment and Location of Headquarters
4.2.5. Analysis by Company Size and Location of Headquarters
4.2.6. Analysis by Type of Industry Served
4.2.7. Analysis by Geographical Coverage
4.2.8. Analysis by Type of Industry Served and Geographical Coverage
4.2.9. Analysis by GMP Compliance
4.2.10. Analysis by Geographical Coverage and GMP Compliance
4.2.11. Analysis by Type of Modular Construction
4.2.12. Analysis by Type of Industry Served and Type of Modular Construction
4.2.13. Analysis by Type of Material Used
4.2.14. Analysis by Type of Modular Construction and Type of Material Used
4.2.15. Analysis of Historical and Current Market Landscape Trends
4.2.15.1 Analysis by Company Size, Geographical Coverage and Type of Industry Served
5. MARKET LANDSCAPE: MODULAR CLEANROOM MANUFACTURERS
5.1. Chapter Overview
5.2. Modular Cleanroom Manufacturers: Overall Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters
5.2.4. Analysis by Year of Establishment and Location of Headquarters
5.2.5. Analysis by Company Size and Location of Headquarters
5.2.6. Analysis by Type of Industry Served
5.2.7. Analysis by Location of Headquarters and Type of Industry Served
5.2.8. Analysis by Type of Modular Cleanroom Offered
5.2.9. Analysis by Type of Industry Served and Type of Modular Cleanroom Offered
5.2.10. Analysis by Type of Cleanroom Component Offered
5.2.11. Analysis by Type of Industry Served and Cleanroom Component Offered
5.2.12. Analysis by Type of Modular Cleanroom and Cleanroom Component Offered
5.2.13. Analysis by Location of Headquarters, Type of Industry Served and Type of Modular Cleanroom Offered
5.2.14. Analysis by Quality Certifications Obtained
6. MODULAR FACILITY MANUFACTURERS: COMPANY COMPETITIVENESS ANALYSIS
6.1 Chapter Overview
6.2 Assumptions / Key Parameters
6.3 Methodology
6.4 Company Competitiveness Analysis: Modular Facility Manufacturers
6.4.1. Company Competitiveness Analysis: Benchmarking of Service Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership activity
6.4.3. Company Competitiveness Analysis: Small Companies
6.4.4. Company Competitiveness Analysis: Mid-Sized Companies
6.4.5. Company Competitiveness Analysis: Large Companies
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Cytiva
7.2.1. Company Overview
7.2.2. Modular Facility-related Services
7.2.3. Modular Projects
7.2.4. Recent Developments and Future Outlook
7.3. G-Con Manufacturing
7.3.1. Company Overview
7.3.2. Modular Facility-related Services
7.3.3. Modular Projects
7.3.4. Recent Developments and Future Outlook
7.4. Germfree
7.4.1. Company Overview
7.4.2. Modular Facility-related Services
7.4.3. Modular Projects
7.4.4. Recent Developments and Future Outlook
7.5. IPM Technologies
7.5.1. Company Overview
7.5.2. Modular Facility-related Services
7.5.3. Modular Projects
7.5.4. Recent Developments and Future Outlook
7.6. KeyPlants
7.6.1. Company Overview
7.6.2. Modular Facility-related Services
7.6.3. Modular Projects
7.6.4. Recent Developments and Future Outlook
7.7. ModuleCo Pharma
7.7.1. Company Overview
7.7.2. Modular Facility-related Services
7.7.3. Modular Projects
7.7.4. Recent Developments and Future Outlook
7.8. NNE
7.8.1. Company Overview
7.8.2. Modular Facility-related Services
7.8.3. Modular Projects
7.8.4. Recent Developments and Future Outlook
7.9. Pharmadule
7.9.1. Company Overview
7.9.2. Modular Facility-related Services
7.9.3. Modular Projects
7.9.4. Recent Developments and Future Outlook
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Modular Facility Manufacturers: Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year of Partnership and Type of Partnership
8.3.4. Analysis by Type of Product
8.3.5. Analysis by Type of Partnership and Type of Product
8.3.6. Analysis by Type of Modular Facility
8.3.7. Analysis by Type of Product and Type of Modular Facility
8.3.8. Most Active Players: Analysis by Number of Partnerships
8.3.9. Analysis by Location of Partner’s Headquarters
8.3.10. Analysis by Location of Modular Facility
8.3.11. Analysis by Type of Partnership and Location of Modular Facility
8.3.12. Analysis by Type of Product and Location of Modular Facility
8.3.13. Intercontinental and Intracontinental Partnerships
8.3.14. Analysis by Country
9. CASE STUDY ON MODULAR PROJECTS IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
9.1. Chapter Overview
9.2. Modular Versus Conventional Construction Methods
9.3. Return on Investment
9.4. Case Study: Facility Based on KUBio Platform
9.4.1. Cytiva KUBio Platform: Overview
9.4.2. Eden Biologics Kubio Modular Project in China: Overview and Construction Details
9.5. Modular Facility Projects Undertaken in the Pharmaceutical and Biotechnology Industry
9.5.1. Analysis by Type of Modular Facility
9.5.2. Analysis by Size of Modular Facility
9.5.3. Most Active Manufacturers: Analysis by Number of Projects Delivered
9.5.4. Leading Clients: Analysis by Number of Projects Received
9.5.5. Analysis by Location of Modular Facility
9.5.6. Analysis by Type of Facility and Size of Modular Facility
9.5.7. Analysis by Client and Location of Facility
10. FACILITY CONSTRUCTION TRENDS IN THE PHARMACEUTICAL INDUSTRY
10.1. Chapter Overview
10.2. Facility Construction Projects Undertaken in the Pharmaceutical / Biotechnology Industry: Historical Data for Top 20 Players
10.2.1. Analysis by Number of Facilities Delivered
10.2.2. Analysis by Type of Facility
10.2.3. Analysis by Purpose of Facility
10.2.4. Analysis by Type of Facility and Purpose of Facility
10.2.5. Analysis by Type of Investment
10.2.6. Analysis by Purpose of Facility and Type of Investment
10.2.7. Analysis by Size of Facility
10.2.8. Analysis by Type of Facility and Size of Facility
10.2.9. Analysis by Purpose of Facility and Size of Facility
10.2.10. Analysis by Location of Headquarters
10.2.11. Analysis by Location of Facility
10.2.12. Analysis by Type of Facility and Location of Facility
11. COST-TIME OPTIMIZATION FRAMEWORK
11.1. Chapter Overview
11.2. Key Parameters
11.3. Key Assumptions and Methodology
11.4. Comparison of Intrinsic Factors
11.4.1. Analysis by Type of Material Used
11.4.2. Analysis by Type of Modular Construction
11.4.1. Analysis by Purpose of Facility
11.4.2. Analysis by Geographical Location
11.5. Integrated Outcome Modeling – Scenario Analysis
11.6. Integrated Outcome Modeling – Output Analysis
11.7. Concluding Remarks
12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Modular Construction Market in the Pharmaceutical / Biotechnology Sector, 2023-2035
12.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Size of Facility, 2023 and 2035
12.4.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Small Facilities, 2023-203
12.4.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mid-sized Facilities, 2023-2035
12.4.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Large Facilities, 2023-2035
12.4.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Very Large Facilities, 2023-2035
12.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Industry Served, 2023 and 2035
12.5.1. Modular Construction Market in the Pharmaceutical Industry, 2023-2035
12.5.2. Modular Construction Market in the Biotechnology Industry, 2023-2035
12.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construct, 2023 and 2035
12.6.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Hybrid Skid Modular Constructs, 2023-2035
12.6.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Skid-Mounted Modular Constructs, 2023-2035
12.6.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Plug-and-Play Modular Constructs, 2023-2035
12.6.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Truckable Modular Constructs, 2023-2035
12.6.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Modular Constructs, 2023-2035
12.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Construction Component, 2023 and 2035
12.7.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Equipment, 2023-2035
12.7.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Base Buildings, 2023-2035
12.7.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Mechanical, Electrical and Plumbing Systems, 2023-2035
12.7.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Process Commodities, 2023-2035
12.7.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Construction Components, 2023-2035
12.8 Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Purpose of Facility, 2023 and 2035
12.8.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Manufacturing, 2023-2035
12.8.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Aseptic Filling, 2023-2035
12.8.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Research and Development, 2023-2035
12.8.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Purposes, 2023-2035
12.9. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Scale of Operation, 2023 and 2035
12.9.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Clinical Scale, 2023-2035
12.9.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Commercial Scale, 2023-2035
12.10. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Product, 2023 and 2035
12.10.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Cell and Gene Therapies, 2023-2035
12.10.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Vaccines, 2023-2035
12.10.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Biosimilars, 2023-2035
12.10.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Monoclonal Antibodies, 2023-2035
12.10.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Advanced Pharmaceuticals, 2023-2035
12.10.6. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Sterile Products, 2023-2035
12.10.7. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Viral Vectors, 2023-2035
12.10.8. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Other Products, 2023-2035
12.11. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Facility, 2023 and 2035
12.11.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for New Facilities, 2023-2035
12.11.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Facility Expansions, 2023-2035
12.11.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Planned Expansions, 2023-2035
12.12. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Modular Construction, 2023 and 2035
12.12.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Relocatable Modular Construction, 2023-2035
12.12.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Permanent Modular Construction, 2023-2035
12.13. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Type of Material Used, 2023 and 2035
12.13.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Steel, 2023-2035
12.13.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Wood, 2023-2035
12.13.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry for Concrete, 2023-2035
12.14. Modular Construction Market in the Pharmaceutical / Biotechnology Industry: Analysis by Geography, 2023 and 2035
12.14.1. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in North America, 2023-2035
12.14.2. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Europe, 2023-2035
12.14.3. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Asia, 2023-2035
12.14.4. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Middle East and North Africa, 2023-2035
12.14.5. Modular Construction Market in the Pharmaceutical / Biotechnology Industry in Rest of the World, 2023-2035
12.15. Concluding Remarks
13. PREVALENT AND EMERGING INDUSTRY TRENDS
13.1. Chapter Overview
13.2. Adoption of Modular Facilities
13.3. Expansion of Existing Service Portfolio
13.4. Integration of Advanced Technologies
13.4.1. Single-use Technologies
13.4.2. Continuous Processing Technologies
13.4.3. Other Advanced Technologies
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Visibility Amongst Start-Ups
14.3. Popularity Amongst Contract Manufacturing Organizations
14.4. Expansion of Existing Facilities
14.5. Adoption for Production of Biosimilars
14.6. Additional Opportunities
14.7. Key Growth Drivers for Modular Construction
14.8. Market Attractiveness in Emerging regions
15. CONCLUSION
16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. Avon Modular
16.2.1. Company Snapshot
16.2.2. Interview Transcript
16.3. Environmental Systems Corporation
16.3.1. Company Snapshot
16.3.2. Interview Transcript
16.4. Exyte
16.4.1. Company Snapshot
16.4.2. Interview Transcript
16.5. G-Con Manufacturing
16.5.1. Company Snapshot
16.5.2. Interview Transcript
16.6. Modular Devices
16.6.1. Company Snapshot
16.6.2. Interview Transcript
16.7. ModWave
16.7.1. Company Snapshot
16.7.2. Interview Transcript
16.8. Subzero Engineering
16.8.1. Company Snapshot
16.8.2. Interview Transcript
16.9. Vernick
16.9.1. Company Snapshot
16.9.2. Interview Transcript
16.10. Zeton
16.10.1. Company Snapshot
16.10.2. Interview Transcript
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
